Provided by Tiger Fintech (Singapore) Pte. Ltd.

Editas Medicine

1.56
+0.230017.29%
Post-market: 1.580.0200+1.28%19:54 EDT
Volume:3.54M
Turnover:5.28M
Market Cap:129.44M
PE:-0.54
High:1.58
Open:1.38
Low:1.38
Close:1.33
Loading ...

Editas Medicine Cut to Underweight From Neutral by JP Morgan

Dow Jones
·
16 Dec 2024

JPMorgan Downgrades Editas Medicine to Underweight From Neutral

MT Newswires Live
·
16 Dec 2024

U.S. RESEARCH ROUNDUP-Amazon, Ford, Netflix

Reuters
·
16 Dec 2024

Analysts Offer Insights on Healthcare Companies: Affimed (AFMD), Editas Medicine (EDIT) and Trevi Therapeutics (TRVI)

TIPRANKS
·
16 Dec 2024

Editas Medicine Inc : JP Morgan Cuts to Underweight From Neutral

THOMSON REUTERS
·
16 Dec 2024

Editas Medicine: Strategic Shift and Uncertainties Prompt Hold Rating

TIPRANKS
·
14 Dec 2024

Editas Medicine price target lowered to $8 from $10 at Baird

TipRanks
·
14 Dec 2024

Brokerages downgrade gene editing company Editas to 'hold', shares slump 23%

Investing.com
·
14 Dec 2024

Editas Medicine Reshapes Future with In Vivo Focus Amid Major Workforce Cuts

GuruFocus.com
·
14 Dec 2024

Editas Medicine Maintains Hold Rating Amid Strategic Shifts and Financial Challenges

TIPRANKS
·
14 Dec 2024

Editas Medicine Is Maintained at Outperform by Baird

Dow Jones
·
13 Dec 2024

Editas Medicine Inc : Stifel Cuts to Hold From Buy

THOMSON REUTERS
·
13 Dec 2024

Truist Downgrades Editas Medicine to Hold From Buy, Removes $8 Price Target

MT Newswires Live
·
13 Dec 2024

Editas Medicine Realigns Strategy to Focus on In Vivo Gene Editing, Targets Human Proof Of Concept By 2026

Benzinga
·
13 Dec 2024

Editas Medicine price target lowered to $3 from $5 at Barclays

TIPRANKS
·
13 Dec 2024

Barclays Keeps Their Hold Rating on Editas Medicine (EDIT)

TIPRANKS
·
13 Dec 2024

Editas Medicine Inc : Baird Cuts Target Price to $8 From $10

THOMSON REUTERS
·
13 Dec 2024

U.S. RESEARCH ROUNDUP-Amazon, Broadcom, Exxon Mobil

Reuters
·
13 Dec 2024

Editas Medicine Inc : RBC Cuts Target Price to $4 From $5

THOMSON REUTERS
·
13 Dec 2024

Editas Medicine Inc : Truist Securities Cuts to Hold From Buy

THOMSON REUTERS
·
13 Dec 2024